Halozyme Therapeutics (HALO) Return on Equity [ROE] (2011 - 2026)
Halozyme Therapeutics' Return on Equity [ROE] was 227.75% in Q2 2026, up 90.99 percentage points from 136.75% a year earlier but down 32.13 percentage points from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Halozyme Therapeutics came in at 153.59%, down 44.83 percentage points from FY2024.
- Return on Equity [ROE] shows a five-year change of +47.27 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was 198.42% in FY2024 (-23.65 pp), 222.07% in FY2023 (+111.85 pp), 110.23% in FY2022 (-121.22 pp) and 231.44% in FY2021 (+125.12 pp).
- Quarterly Return on Equity [ROE] has moved between 105.77% (Q3 2024) and 259.88% (Q1 2026) over five years.
- Compared with a year earlier, Return on Equity [ROE] has increased for four straight quarters, with an average year-over-year change of +7.57 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q3 2021 (a gain of 182.78 percentage points); the worst was Q1 2025 (a drop of 128.99 percentage points).
- Per Business Quant data, HALO's Return on Equity [ROE] in the three quarters before Q2 2026 was 259.88% (Q1 2026), 114.66% (Q4 2025) and 142.35% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Halozyme Therapeutics | 12.53 Bn | 11.13 Bn | 401.83 Mn | 227.75% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 227.75% |
| Mar 31, 2026 | 259.88% |
| Dec 31, 2025 | 114.66% |
| Sep 30, 2025 | 142.35% |
| Jun 30, 2025 | 136.75% |
| Mar 31, 2025 | 114.73% |
| Dec 31, 2024 | 108.78% |
| Sep 30, 2024 | 105.77% |
| Jun 30, 2024 | 144.38% |
| Mar 31, 2024 | 243.72% |
| Dec 31, 2023 | 169.13% |
| Sep 30, 2023 | 126.89% |
| Jun 30, 2023 | 215.51% |
| Mar 31, 2023 | 154.16% |
| Dec 31, 2022 | 151.53% |
| Sep 30, 2022 | 108.26% |
| Jun 30, 2022 | 132.32% |
| Mar 31, 2022 | 190.25% |
| Dec 31, 2021 | 168.28% |
| Sep 30, 2021 | 203.83% |
API Access
Halozyme Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();